Predict your next investment

HEALTHCARE | Medical Devices & Equipment
phagenesis.com

See what CB Insights has to offer

Executives

4

Board of Directors

3

Phagenesis Board of Directors

3 Board of directors

Phagenesis has 3 board of directors, including Henry Hyde Thomson.

Name

Firm

Work History

Other Seats

Henry Hyde Thomson

Phagenesis

Oern Stuge

Phagenesis

Oliver Hofmann

15 years experience in medical diagnostics industry in senior technical, operational and business development roles. Ex Director of Operations and Non-Executive Director at Imperial College spin-out Molecular Vision Ltd. a VC backed developer of disruptive diagnostic tests for the point-of-care. Also performed business development for Abingdon Health, a specialist medical diagnostics commercialisation company, after its acquisition of Molecular Vision. Most recently Senior Investment Manager at Inventages, a leading global healthcare VC fund. PhD in Microfluidics from Imperial College and MBA from Imperial College Business School.

Phagenesis

Name

Henry Hyde Thomson

Oern Stuge

Oliver Hofmann

Firm

Work History

15 years experience in medical diagnostics industry in senior technical, operational and business development roles. Ex Director of Operations and Non-Executive Director at Imperial College spin-out Molecular Vision Ltd. a VC backed developer of disruptive diagnostic tests for the point-of-care. Also performed business development for Abingdon Health, a specialist medical diagnostics commercialisation company, after its acquisition of Molecular Vision. Most recently Senior Investment Manager at Inventages, a leading global healthcare VC fund. PhD in Microfluidics from Imperial College and MBA from Imperial College Business School.

Other Seats

Phagenesis

Phagenesis

Phagenesis

Phagenesis Management Team

4 Team Members

Phagenesis has 4 executives. Phagenesis's current Chief Executive Officer is Daniel Green.

Name

Work History

Title

Status

Daniel Green

RepRegen, Imperial Innovations, HBM Partners, MVM Partners, and Financial Times

Chief Executive Officer

Current

Reinhard Krickl

Chief Executive Officer, President

Current

Conor Mulrooney

Chief Operating Officer

Current

Shaheen Hamdy

Chief Security Officer

Current

Name

Daniel Green

Reinhard Krickl

Conor Mulrooney

Shaheen Hamdy

Work History

RepRegen, Imperial Innovations, HBM Partners, MVM Partners, and Financial Times

Title

Chief Executive Officer

Chief Executive Officer, President

Chief Operating Officer

Chief Security Officer

Status

Current

Current

Current

Current

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.